Category

China’s Social Credit System

China is building submarines faster than ever, think tank says. Why that’s a problem for Washington China's Social Credit System

China is building submarines faster than ever, think tank says. Why that’s a problem for Washington

China has ramped up its production of nuclear-powered submarines over the past five years to the point where it is launching subs faster than the United States, threatening to negate a sea-power advantage that has long belonged to Washington, a new think tank report says. The buildup in the People’s…
bubmag
February 17, 2026
Octopus Energy invests $1 billion in California clean technology China's Social Credit System

Octopus Energy invests $1 billion in California clean technology

Octopus Energy will acquire a solar and storage project in California that is expected to be operational by July as part of its investment. The UK-based company, active across major markets in Europe, Australia, China and the United States, says California’s clean technology sector will “bring innovation...Read More
bubmag
February 17, 2026
EU companies adopt BYD, Yutong buses despite China security fears China's Social Credit System

EU companies adopt BYD, Yutong buses despite China security fears

Electric buses made by China’s BYD and Yutong are increasingly popular in Germany and neighboring countries, despite misgivings in Europe about ceding infrastructure control to Chinese companies. Transportation companies in Germany, Belgium, and Austria are adding China-made electric buses to their fleets, with operators saying they are cheaper and better…
bubmag
February 17, 2026
Sagrada Madre enters mainland China after building a following in Hong Kong China's Social Credit System

Sagrada Madre enters mainland China after building a following in Hong Kong

In the corridors of MixC Shenzhen Bay, one storefront stops passersby mid-stride. Washed in earthy reds and raw wood textures, the space feels less like a cosmetics counter and more like a fragment of South America transplanted into southern China. The air carries a dense blend of herbs and fruit,…
bubmag
February 16, 2026
InnoCare Announces First Patient Dosed in the Phase II/III Clinical Trial of Novel TYK2 Inhibitor Soficitinib for Chronic Spontaneous Urticaria in China China's Social Credit System

InnoCare Announces First Patient Dosed in the Phase II/III Clinical Trial of Novel TYK2 Inhibitor Soficitinib for Chronic Spontaneous Urticaria in China

Article content BEIJING, Feb. 12, 2026 (GLOBE NEWSWIRE) — InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the first patient has been dosed in the Phase II/III clinical trial of novel TYK2 inhibitor soficitinib (ICP-332) for…
bubmag
February 13, 2026